The findings underscore the need to treat heart failure with urgency and double down on clinician education, one expert says.

Approximately one in four patients died, deteriorated to a higher shock stage, or were transferred for a higher level of care ...

The novel CETP inhibitor, once tested for the now-defunct pathway of HDL raising, reduces LDL as well as Lp(a).